Mingjiao Sun
Impact in
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Immunotherapy and Immune Responses 4
- Immune cells in cancer 2
- Journals
- PLoS ONE (3 papers)Journal of the American Chemical Society (1 paper)Acta Pharmaceutica Sinica B (1 paper)Infectious Diseases (1 paper)Apmis (1 paper)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Mingjiao Sun
20 papers receiving 575 citations
Peers
Comparison fields: 5 of 91
- Clinical Biochemistry 55
- Infectious Diseases 116
- Immunology 129
- Biomaterials 79
- Molecular Medicine 20
Countries citing papers authored by Mingjiao Sun
This map shows the geographic impact of Mingjiao Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjiao Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjiao Sun more than expected).
Fields of papers citing papers by Mingjiao Sun
This network shows the impact of papers produced by Mingjiao Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjiao Sun. The network helps show where Mingjiao Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingjiao Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 51 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 22 | |
| 6 | 2022 | 49 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 85 | |
| 9 | 2021 | 18 | |
| 10 | 2020 | 90 | |
| 11 | 2020 | 5 | |
| 12 | 2019 | 19 | |
| 13 | 2017 | 45 | |
| 14 | 2016 | 10 | |
| 15 | 2015 | 5 | |
| 16 | 2013 | 38 | |
| 17 | 2013 | 31 | |
| 18 | 2012 | 47 | |
| 19 | 2012 | 38 | |
| 20 | 2011 | 12 |
About Mingjiao Sun
Mingjiao Sun is a scholar working on Immunology, Clinical Biochemistry, Biomaterials, Infectious Diseases and Virology, having authored 20 papers that have together received 583 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Immunotherapy and Immune Responses (4 papers), Streptococcal Infections and Treatments (4 papers), Bacterial biofilms and quorum sensing (3 papers), CAR-T cell therapy research (2 papers), RNA Interference and Gene Delivery (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Clinical Biochemistry (55 citations), Infectious Diseases (116 citations), Immunology (129 citations), Biomaterials (79 citations) and Molecular Medicine (20 citations). Mingjiao Sun has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Mingna Sun, Jianye Zhang, Feihu Wang, Qi Shang, Yao Xu, Yun Su, James J. Moon, Yonghyun Lee, Kyong Soo Park and Marisa Aikins. Their work appears in journals such as PLoS ONE, Journal of the American Chemical Society, Acta Pharmaceutica Sinica B, Infectious Diseases and Apmis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.